Director Coliseum Capital Management sold $124.2M in UTI shares at $41.40, reducing its stake by 75.5% from a position near the 90-day high. This large-scale exit by a frequent seller, with no other insider buyers in the last 60 days, suggests a significant reduction in conviction despite a STRONG BUY analyst consensus.

Where it could go — Analyst mean target not provided; bear case if stock breaks the recent low of $31.42.

SVP & CAO Christine Kline sold $155K worth of shares, reducing her stake by 7.5% at a price 41.4% above the 90-day low. This first-ever sale is a routine diversification event, lacking the corroboration of other insider buying to signal deeper concern.

Where it could go — Analyst mean target not provided; bear case if stock breaks below the recent low of $31.42.

Director Linda J. Sreere filed a Form 4 Code-S (open-market sale) for $549K, reducing her stake by 10.5%. This is her first recorded transaction, with no prior Code-P buys or Code-S sells on file. The sale at $36.59 is 40.0% above the 90-day low, and analyst consensus remains a Strong Buy with 10 buy ratings.

Where it could go — If the bear case plays out, the stock may test the 90-day low of $26.13; the bull case requires the stock to hold above the $31.42 30-day low and align with the analyst consensus.